Pediatric Abdominal Pain Clinical Trial
— MCAPOfficial title:
Parent Training to Address Pediatric Functional Abdominal Pain
| NCT number | NCT01620606 |
| Other study ID # | 13744 SCH |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | September 2011 |
| Est. completion date | May 2017 |
| Verified date | April 2021 |
| Source | University of Washington |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Functional abdominal pain (FAP) is a common complaint of childhood, associated with considerable health care costs, disruption of normal activity, emotional distress, and long-term health effects. The study will test a treatment approach which, if successful, would substantially change the treatment for FAP and potentially for a wide range of childhood medical problems where parental responses to symptoms contribute to these adverse effects. The study would also provide a model which would be much more accessible than traditional face-to-face therapies to a broader range of families in need than are currently served.
| Status | Completed |
| Enrollment | 316 |
| Est. completion date | May 2017 |
| Est. primary completion date | May 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 7 Years to 12 Years |
| Eligibility | Inclusion Criteria: - The child is 7 to 12 years old - The child experienced at least three episodes of unexplained abdominal pain over a three month period which affected the child's activities - The child lived with the primary caregiver for at least the last 3 months - The child and the parent agree to the conditions of study participation, including randomization, participation in intervention and follow-up evaluations - The parent and child comprehend and speak English without assistance Exclusion Criteria: - The child has positive physical or laboratory findings which would explain the abdominal pain - The child has a chronic disease (e.g. Crohn's, ulcerative colitis, pancreatitis, diabetes, epilepsy, etc.) - The child is lactose intolerant - The child had major surgery in the past year - The parent or child has developmental disabilities that require full-time special education or that impair ability to respond to assessment measures |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of North Carolina | Chapel Hill | North Carolina |
| United States | Seattle Children's Hospital | Seattle | Washington |
| United States | Mary Bridge Children's Hospital | Tacoma | Washington |
| Lead Sponsor | Collaborator |
|---|---|
| University of Washington | MultiCare Mary Bridge Children's Hospital & Health Center, University of North Carolina |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Abdominal Pain Index | Baseline, 1 week post treatment session 3, 3 months post treatment session 3, 6 months post treatment session 3, 12 months post treatment session 3 | ||
| Secondary | Adults' Responses to Children's Symptoms | Baseline, 1-3 days post treatment session 1, 1-3 days post treatment session 2,1 week post treatment session 3, 3 months post treatment session 3, 6 months post treatment session 3, 12 months post treatment session 3 | ||
| Secondary | Pain Response Inventory | Baseline, 1 week post treatment session 3, 3 months post treatment session 3, 6 months post treatment session 3, 12 months post treatment session 3 | ||
| Secondary | Pain Beliefs Questionnaire | Baseline, 1 week post treatment session 3, 3 months post treatment session 3, 6 months post treatment session 3, 12 months post treatment session 3 | ||
| Secondary | Pain Catastrophizing Scale | Baseline, 1-3 days post treatment session 1, 1-3 days post treatment session 2,1 week post treatment session 3, 3 months post treatment session 3, 6 months post treatment session 3, 12 months post treatment session 3 |